courses
2681
Students who commenced study in 2015 should refer to this course entry for direction on the requirements; to check which units are currently available for enrolment, refer to the unit indexes in the the current edition of the Handbook. If you have any queries contact the managing faculty for your course.
This course entry applies to students commencing this course in 2015 and should be read in conjunction with information provided in the 'Faculty information' section of this Handbook by the Faculty of Business and Economics.
Course code | 2681 |
---|---|
Managing faculty | Business and Economics |
Abbreviated title | GradCertPharmEc |
Total credit points required | 24 |
Standard duration of study (years) | 1 year PT Part-time study only |
Study mode and location | Off-campus (Clayton) |
Admission, fee and application details | http://www.monash.edu/study/coursefinder/course/2681 |
Contact details | Visit http://www.buseco.monash.edu.au/findoutmore/current-students.html |
Course coordinator |
Notes
This course is designed to provide an understanding of the economics of pharmaceuticals in health care systems, and the skills required to apply economic analysis to the evaluation of products and the broad policy issues affecting the industry.
Areas of study include cost-effectiveness analysis of a drug, economic modelling to support the inclusion or exclusion of a drug on a national or hospital formulary, design of a clinical trial to evaluate the efficacy and cost-effectiveness of drugs, and methods of evaluating health and non-health outcomes of drug use.
These course outcomes are aligned with the Australian Qualifications Framework level 8, the Bologna Cycle 1 and Monash Graduate AttributesAustralian Qualifications Framework level 8, the Bologna Cycle 1 and Monash Graduate Attributes (http://www.monash.edu.au/pubs/handbooks/alignmentofoutcomes.html).
Upon successful completion of this course it is expected that graduates will:
(a.) be critical and creative scholars who:
(b.) be responsible and effective global citizens who:
(c.) have a comprehensive understanding of their disciplines of economics and health economics and be able to provide discipline-based solutions relevant to the business, professional and public policy communities we serve
(d.) have advanced knowledge to graduate certificate level in health economics and be able to:
This course consists of four units.
Students must complete:
(a.) three units (18 points) as follows:
(b.) one of the following units (6 points):
Students who successfully complete the Graduate Certificate in Pharmacoeconomics, may be eligible for admission to course 3807 Graduate Diploma in Health Economics and Policy subject to satisfying the appropriate entry requirementsentry requirements (http://www.monash.edu/study/coursefinder/course/3807).
Graduate Certificate of Pharmacoeconomics